caution larry

Hi, I’m Kim! This site provides a little insight to my journey of being diagnosised with Remitting Relapsing Multiple Sclerosis on October 26th 2004. I review books and documentaries, post MS-related news, and share my photos.

Subscribe (RSS)

no larry

My bloglines

Archives

Current

November 2004
December 2004
January 2005
February 2005
March 2005
April 2005
May 2005
June 2005
July 2005
August 2005
September 2005
October 2005
November 2005
December 2005
January 2006
February 2006
March 2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
January 2008
February 2008
March 2008
April 2008
May 2008
June 2008
July 2008
August 2008
September 2008
October 2008
November 2008
December 2008
January 2009
February 2009
March 2009
April 2009
May 2009
June 2009
July 2009
August 2009
September 2009
October 2009
November 2009
December 2009
January 2010
February 2010
March 2010
May 2010
June 2010
July 2010
September 2010
November 2011

 

Wednesday, October 14, 2009
Not quite diagnosed yet?
 
Copaxone has a treatment solution for you now. Good on them for getting to you sooner rather than later! We all know the diagnosing cycle can be a lengthy one. Man, I was lucky. 3 months I believe and I was diagnosed. And not all that many doctors in comparison to what I've heard from many of you. Anyways, have a read.

"The researchers found that the treatment group had a 45 percent reduced risk of developing MS during the course of the study compared with the placebo group. In addition, 24.7 percent of the treatment group had a second clinical attack compared to 42.9 percent of the placebo group. The length of time for 25 percent of patients to develop MS was extended from 336 days for the control group to 722 days for the treatment group. Injection-site and post-injection reactions were more common in the treatment group as compared to placebo group.

"Early treatment with glatiramer acetate is efficacious in delaying conversion to clinically definite MS in patients presenting with clinically isolated syndrome and brain lesions detected by MRI," the authors conclude."


Sunday, October 11, 2009
Happy Thanksgiving!
 
Happy Thanksgiving everyone! I hope you're all having good turkey and family time. I'm done one turkey dinner and the next one is tonight! Mmmmm... I need to go make cranberry sauce now.

DSC_0022


Friday, October 9, 2009
 
I got home from work today and this is what it all looked like:

Savoy was catching on blogs

DSC_0045

Flick wanted to go get some food (I think)

DSC_0026

But he was blocked by sleeping Lady Sadie

DSC_0027

But she woke up with that pleading look "take me out"

DSC_0028

So she went to get ready

DSC_0039

DSC_0030

And we left our condo..ohhh look out, thats where the skunks hang out!

DSC_0031

To the park for a good shake

DSC_0034

And err... the necessary...

DSC_0032

Checking out the park

DSC_0036

And back home

DSC_0038

Sadie just turned 13 last week, so walks are pretty slow. And not so long anymore.



A sneak peak

 
Bed time at my full house these days...

Starts with a yawn

DSC_0019

And a stretch right to the tippy toes

DSC_0023

Then some settling in

DSC_0025

And more

DSC_0006

DSC_0010

And some protective action for the important things in life

DSC_0002

And everyones comfy!

DSC_0039


Thursday, October 1, 2009
And just because
 
My nephew has now perfectly mastered the "Cabbage Patch" look:

Cabbage Patch kid impersonator

And I still take lots of photos my pets :) This is where Sadie chooses to sit when we take her out on a boat ride.

DSC_0038



Fingolimod - FTY720 news

 
Of course I have to post this news right away. I take this lovely little pill! :)

"According to Novartis, the study met its primary and secondary endpoints for both the 0.5 mg and 1.25 mg doses, with no significant difference in efficacy between doses. The results showed that FTY720 reduced the relapse rate by 54% for the 0.5 mg dose and 60% for the 1.25 mg dose, compared with placebo. In addition, it reduced the progression of disability by 30% for patients on 0.5 mg and 32% for those on 1.25 mg, compared with placebo over two years."



Blood test could predict severity of your MS

 
Hmmmm... this opens up a lot of questions for me. Would you really want to know? Would there be a better treatment you would choose knowing the course of your disease? Hmph. The drugs on the market now seem to have such similar efficacy rates, so really? Does it matter? Have a read for yourself and leave a comment with your thoughts!

"Research has identified a biological marker in blood that seems linked to patients’ prognosis after the first MS attack, paving the way for a new approach to assessing how the illness will progress. If a blood test based on the biomarker can be validated, it could be used with MRI scans and other methods to improve diagnosis.

Patients whose MS is thought likely to progress quickly could be started swiftly on therapies that can reduce the frequency and severity of attacks, while those at lower risk could be spared medication they do not need immediately. More accurate ways of assessing prognosis could also help to prepare patients for what they should expect in the future, removing the uncertainty that can be a distressing feature of the disease.

The research, led by Rachel Farrell, of the Institute of Neurology at University College London, and funded by the MS Society, also offers new insights into the biology of MS that could improve understanding of the causes of the condition."